Overview

Phase II Iressa + Irradiation Followed by Chemo in NSCLC

Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine wether the ZD1839 associated with a radiotherapy, before the beginning of chemotherapy is effective in the treatment of your disease and to evaluate the tolerance of these treatments.
Phase:
Phase 2
Details
Lead Sponsor:
AstraZeneca
Treatments:
Gefitinib
Vinorelbine